Jackson Park Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Jackson Park Capital’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-4,200	Closed	-$224K	–	54
2016 Q1	$224K	Buy	+4,200	New	+$310K	0.29%	41
2015 Q1	–	Sell	-32,700	Closed	-$1.05M	–	41
2014 Q4	$1.05M	Buy	+32,700	New	+$982K	0.84%	33

Other funds holding ANAC

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $417M AUM 49.77% 1-Year Est. Return

Jackson Park Capital's ANAC Position: Q2 2016 in Review

Jackson Park Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 4,200 shares — an estimated $224K sold.

Jackson Park Capital first reported a position in ANAC in Q4 2014 and held it in 2 quarters. The position peaked at $1.05M in Q4 2014. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Jackson Park Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Jackson Park Capital sold 4,200 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $224K.
Jackson Park Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 2 quarters.
Jackson Park Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $1.05M in Q4 2014.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Jackson Park Capital's 13F filing for Q2 2016, filed 28 Jul 2016.